Market Exclusive

Analyst Activity – Cann Reiterates Hold on NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA)

Analyst Ratings For NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA)

Today, Cann reiterated its Hold rating on NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA).

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA)
NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA) has insider ownership of 3.20% and institutional ownership of 57.49%.

Recent Trading Activity for NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA)
Shares of NASDAQ:NTLA – Intellia Therapeutics closed the previous trading session at 20.68 up +0.66 3.30% with 21.100000381469727 shares trading hands.

Exit mobile version